Device type · OAD
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OAD
Cardiovascular
Device class
Class III
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
263
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter
- Product code
- OAD
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Electrophysiology
- FDA record
- Classification database entry for OAD
Latest FDA decisions
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
- THERMOCOOL SMARTTOUCH® SF CatheterPMA supplement
P030031-S100 · Decided Sep 30, 2020 · 282 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
P150005 · Decided Feb 24, 2016 · 387 days after receipt
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
Reports received
263
Received Nov 1, 2025 to Nov 19, 2026. Includes 7 of another or unstated type.
Malfunction reports
140
53% of reports
Injury reports
106
40% of reports
Death reports
10
3.8% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 24 | 10 | 0 | 0 |
| Jan 24 | 20 | 18 | 1 | 0 |
| Feb 24 | 19 | 12 | 3 | 0 |
| Mar 24 | 13 | 12 | 2 | 0 |
| Apr 24 | 14 | 5 | 0 | 0 |
| May 24 | 14 | 8 | 0 | 0 |
| Jun 24 | 18 | 7 | 0 | 0 |
| Jul 24 | 13 | 4 | 1 | 0 |
| Aug 24 | 13 | 4 | 0 | 0 |
| Sep 24 | 16 | 5 | 1 | 0 |
| Oct 24 | 14 | 11 | 0 | 0 |
| Nov 24 | 10 | 16 | 0 | 0 |
| Dec 24 | 14 | 2 | 0 | 0 |
| Jan 25 | 6 | 5 | 0 | 0 |
| Feb 25 | 8 | 7 | 0 | 0 |
| Mar 25 | 12 | 7 | 0 | 0 |
| Apr 25 | 15 | 2 | 0 | 0 |
| May 25 | 6 | 5 | 0 | 0 |
| Jun 25 | 8 | 10 | 0 | 0 |
| Jul 25 | 10 | 5 | 1 | 0 |
| Aug 25 | 10 | 2 | 1 | 0 |
| Sep 25 | 8 | 11 | 0 | 0 |
| Oct 25 | 10 | 9 | 0 | 0 |
| Nov 25 | 11 | 4 | 0 | 0 |
| Dec 25 | 11 | 11 | 1 | 0 |
| Jan 26 | 14 | 8 | 1 | 0 |
| Feb 26 | 17 | 8 | 0 | 0 |
| Mar 26 | 16 | 6 | 0 | 0 |
| Apr 26 | 10 | 3 | 1 | 0 |
| May 26 | 14 | 2 | 1 | 0 |
| Jun 26 | 11 | 5 | 1 | 0 |
| Jul 26 | 7 | 34 | 2 | 0 |
| Aug 26 | 7 | 6 | 0 | 2 |
| Sep 26 | 10 | 10 | 0 | 3 |
| Oct 26 | 12 | 9 | 3 | 2 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem78
- Patient Device Interaction Problem40
- Nonstandard Device21
- Fluid/Blood Leak13
- Temperature Problem10
- Obstruction of Flow9
- No Flow8
- Signal Artifact/Noise8
- Restricted Flow rate7
- Device Sensing Problem6
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions138
- Cardiac Perforation23
- Cardiac Tamponade23
- Cardiac Arrest11
- Heart Block11
- Respiratory Failure11
- Low Blood Pressure/ Hypotension9
- Insufficient Information8
- Stroke/CVA8
- Tachycardia8
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Medtronic Sphere-9 Catheter, Model Number AFR-00001; catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.Open, Classified
Z-1948-2026 · Started Mar 11, 2026 · Posted by FDA Apr 24, 2026
Reason given: Ventricular fibrillation (VF) occurred during radiofrequency (RF) therapy with the Medtronic Sphere-9 catheter in patients who have a Biotronik Implantable Cardioverter Defibrillator (ICD) or Biotronik Cardiac Resynchronization Therapy-Defibrillator (CRT-D) implanted. The observation is caused by an interaction...
Cause as FDA categorized it: Device Design
Johnson & Johnson Surgical Vision, Inc.
Z-0169-2023 · Started Sep 7, 2022 · Posted by FDA Nov 2, 2022
Reason given: Manufacturing error resulted in potential contamination of Bi-Directional navigation catheter irrigation path with cellulose fibers that can cause 1) Failure of initial flushing inspection, 2) Insufficient irrigation causing catheter tip temperature increase, limiting the ability to deliver ablation, or 3) particles...
Cause as FDA categorized it: Process control
Z-0699-2019 · Started Nov 28, 2018
Reason given: Supplier had changed its resin sub-suppliers three (3) times without notifying BSC. These changes resulted in slight variations in resin material compositions which were not reflected in BSC s internal product documentation. Not approved in customer document.
Cause as FDA categorized it: Nonconforming Material/Component
Z-0700-2019 · Started Nov 28, 2018
Reason given: Supplier had changed its resin sub-suppliers three (3) times without notifying BSC. These changes resulted in slight variations in resin material compositions which were not reflected in BSC s internal product documentation. Not approved in customer document.
Cause as FDA categorized it: Nonconforming Material/Component
Z-0701-2019 · Started Nov 28, 2018
Reason given: Supplier had changed its resin sub-suppliers three (3) times without notifying BSC. These changes resulted in slight variations in resin material compositions which were not reflected in BSC s internal product documentation. Not approved in customer document.
Cause as FDA categorized it: Nonconforming Material/Component
Z-0202-2019 · Started Jun 20, 2018 · Posted by FDA Aug 28, 2018
Reason given: Reports of unintended continuation of radiofrequency (RF) energy delivery from the Cardiac ablation system after the foot switch has been released.
Z-0462-2016 · Started Nov 20, 2015
Reason given: During routine monitoring of complaints, BSC noted that the IntellaTip MiFi XP N4 complaint rate for distal tip bends/kinks was above the anticipated rate in BSC's product risk documentation.
Cause as FDA categorized it: Device Design
Z-0463-2016 · Started Nov 20, 2015
Reason given: During routine monitoring of complaints, BSC noted that the IntellaTip MiFi XP N4 complaint rate for distal tip bends/kinks was above the anticipated rate in BSCs product risk documentation.
Cause as FDA categorized it: Device Design
Showing the 8 newest of 22 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.